학술논문
Cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort (EC) in a phase I study
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15698041